Found 12 hits for monomerid = 330029 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Non-receptor tyrosine-protein kinase TYK2
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
US Patent
| Assay Description Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &... |
US Patent US9663526 (2017)
BindingDB Entry DOI: 10.7270/Q2CV4KVD |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
US Patent
| |
US Patent US9663526 (2017)
BindingDB Entry DOI: 10.7270/Q2CV4KVD |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 3.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
US Patent
| |
US Patent US9663526 (2017)
BindingDB Entry DOI: 10.7270/Q2CV4KVD |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
US Patent
| |
US Patent US9663526 (2017)
BindingDB Entry DOI: 10.7270/Q2CV4KVD |
More data for this Ligand-Target Pair | |
Non-receptor tyrosine-protein kinase TYK2
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
US Patent
| Assay Description Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &... |
US Patent US10463675 (2019)
BindingDB Entry DOI: 10.7270/Q2VT1VGN |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 3.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
US Patent
| Assay Description Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &... |
US Patent US10463675 (2019)
BindingDB Entry DOI: 10.7270/Q2VT1VGN |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
US Patent
| Assay Description Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &... |
US Patent US10463675 (2019)
BindingDB Entry DOI: 10.7270/Q2VT1VGN |
More data for this Ligand-Target Pair | |
Non-receptor tyrosine-protein kinase TYK2
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | n/a | n/a | 4.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK2
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | n/a | n/a | 3.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
|
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK1
(Homo sapiens (Human)) | BDBM330029
(US10463675, Example 112 | US11197867, Example 112 ...)Show SMILES CCNC(=O)c1ccc(Nc2ncc(F)c(n2)N2CC3CC(C2)N3C(=O)C(C)(C)F)cc1C |THB:15:17:23:20| Show InChI InChI=1S/C23H28F2N6O2/c1-5-26-20(32)17-7-6-14(8-13(17)2)28-22-27-10-18(24)19(29-22)30-11-15-9-16(12-30)31(15)21(33)23(3,4)25/h6-8,10,15-16H,5,9,11-12H2,1-4H3,(H,26,32)(H,27,28,29) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc.
US Patent
| Assay Description Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &... |
US Patent US10463675 (2019)
BindingDB Entry DOI: 10.7270/Q2VT1VGN |
More data for this Ligand-Target Pair | |